CervoMed
CRVO
12 hedge funds and large institutions have $1.68M invested in CervoMed in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.
185% more capital invested
Capital invested by funds: $590K → $1.68M (+$1.09M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
1.3% more ownership
Funds ownership: 5.78% → 7.08% (+1.3%)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$403K |
| 3 |
Renaissance Technologies
New York
|
+$11.9K |
| 4 |
HI
Hoey Investments
Coatesville,
Pennsylvania
|
+$5.44K |
| 5 |
Citigroup
New York
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$122K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$55K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.61K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.63K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$200 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Adage Capital Partners
Boston,
Massachusetts
| $921K | +$1M | +199,347 | New |
|
|
RSCM
2
Rock Springs Capital Management
Baltimore,
Maryland
| $370K | +$403K | +80,033 | New |
|
|
3
Renaissance Technologies
New York
| $135K | +$11.9K | +2,360 | +9% |
|
4
BlackRock
New York
| $101K | -$5 | -1 | -0% |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $92K | -$122K | -24,239 | -55% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $52.9K | -$1.63K | -323 | -3% |
|
|
HI
7
Hoey Investments
Coatesville,
Pennsylvania
| $4.99K | +$5.44K | +1,080 | New |
|
8
Osaic Holdings
Scottsdale,
Arizona
| $1.82K | -$5 | -1 | -0.3% |
|
9
Morgan Stanley
New York
| $1.68K | -$5 | -1 | -0.3% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $1.37K | -$6.61K | -1,311 | -82% |
|
11
Wells Fargo
San Francisco,
California
| $46 | – | – | – |
|
|
12
Citigroup
New York
| $5 | +$5 | +1 | New |
|
|
BCM
13
Bridgeway Capital Management
Houston,
Texas
| – | -$55K | -11,043 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$200 | -40 | Closed |
|
CRVO Hedge Fund Activity: Q3 2023 in Review
12 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2023, worth a combined $1.68M — up 185% from $590K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CRVO positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $1M. The largest seller was Vanguard Group, cutting an estimated $122K.
- 12 institutional investors held CervoMed (CRVO) as of Q3 2023, up from 11 in Q2 2023.
- Funds reported $1.68M of CervoMed stock for Q3 2023, up 185% quarter-over-quarter.
- 4 funds opened new CervoMed positions in Q3 2023 and 2 closed out, a net change of +2 holders.
- The largest CervoMed buyer in Q3 2023 was Adage Capital Partners, an estimated $1M added.
- The largest CervoMed seller in Q3 2023 was Vanguard Group, an estimated $122K sold.
Based on aggregated 13F filings for Q3 2023.